Mixed Phenotype Acute Leukemia
Oncology·MeSH: Leukemia, Biphenotypic, Acute
Prevalence
30.0 / 100K
0 drugs in development·0 companies·13 clinical trials
Frequently asked questions
How many clinical trials target Mixed Phenotype Acute Leukemia?
There are 13 clinical trials targeting Mixed Phenotype Acute Leukemia tracked by BioSniper.
What is the prevalence of Mixed Phenotype Acute Leukemia?
The estimated prevalence of Mixed Phenotype Acute Leukemia is approximately 30.0 per 100,000 population.
Deep-dive into Mixed Phenotype Acute Leukemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis